Aileron Therapeutics Stock Alpha and Beta Analysis
| ALRN Stock | USD 2.86 0.12 4.38% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Aileron Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Aileron Therapeutics over a specified time horizon. Remember, high Aileron Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Aileron Therapeutics' market risk premium analysis include:
Beta 0.19 | Alpha 0.42 | Risk 6 | Sharpe Ratio 0.0432 | Expected Return 0.26 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Aileron |
Aileron Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Aileron Therapeutics market risk premium is the additional return an investor will receive from holding Aileron Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Aileron Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Aileron Therapeutics' performance over market.| α | 0.42 | β | 0.19 |
Aileron Therapeutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Aileron Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how Aileron Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Aileron Therapeutics Market Price Analysis
Market price analysis indicators help investors to evaluate how Aileron Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aileron Therapeutics shares will generate the highest return on investment. By understating and applying Aileron Therapeutics stock market price indicators, traders can identify Aileron Therapeutics position entry and exit signals to maximize returns.
Aileron Therapeutics Return and Market Media
The median price of Aileron Therapeutics for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 is 3.46 with a coefficient of variation of 15.3. The daily time series for the period is distributed with a sample standard deviation of 0.5, arithmetic mean of 3.28, and mean deviation of 0.45. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Disposition of 17064 shares by Musso Alan A of Aileron Therapeutics at 4.63 subject to Rule 16b-3 | 09/13/2024 |
2 | Aileron Therapeutics Completes Enrollment in Cohort 2 of the Ongoing Phase 1b Clinical Trial Evaluating LTI-03 in Idiopathic Pulmonary Fibrosis | 09/23/2024 |
3 | University of Texas Texas AM Investment Management Co. Invests 4.93 Million in Aileron Therapeutics, Inc. - MarketBeat | 10/02/2024 |
4 | KCK LTD. Adjusts Stake in NeuroPace Inc | 10/25/2024 |
5 | Disposition of 6291 shares by University Of Texastexas Am Investment Management Co of Aileron Therapeutics at 3.3 subject to Rule 16b-3 | 11/07/2024 |
6 | Aileron Therapeutics Investigational Drug Shows Encouraging Action In Lung Fibrosis | 11/13/2024 |
7 | Disposition of 337 shares by University Of Texastexas Am Investment Management Co of Aileron Therapeutics at 4.28 subject to Rule 16b-3 | 11/29/2024 |
About Aileron Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Aileron or other stocks. Alpha measures the amount that position in Aileron Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Interest Debt Per Share | 0.0104 | 0.009916 | Revenue Per Share | 1.1K | 941.06 |
Aileron Therapeutics Upcoming Company Events
As portrayed in its financial statements, the presentation of Aileron Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Aileron Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Aileron Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Aileron Therapeutics. Please utilize our Beneish M Score to check the likelihood of Aileron Therapeutics' management manipulating its earnings.
| 18th of March 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 18th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Aileron Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Aileron Therapeutics Backtesting, Aileron Therapeutics Valuation, Aileron Therapeutics Correlation, Aileron Therapeutics Hype Analysis, Aileron Therapeutics Volatility, Aileron Therapeutics History and analyze Aileron Therapeutics Performance. To learn how to invest in Aileron Stock, please use our How to Invest in Aileron Therapeutics guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Aileron Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.